UTHR - United Therapeutics GAAP EPS of $4.36 beats by $0.17 revenue of $614.7M beats by $38.83M February, 21 2024 06:02 AM United Therapeutics Corporation 2024-02-21 06:02:03 ET More on United Therapeutics Anticompetitive Behavior At United Therapeutics United Therapeutics: Cheap With Litigation Headwinds Liquidia jumps on win in patent case against United Therapeutics (update) Seeking Alpha’s Quant Rating on United Therapeutics For further details see: United Therapeutics GAAP EPS of $4.36 beats by $0.17, revenue of $614.7M beats by $38.83M